Skip to main content
TipRanks
Go Ultimate75% OFF

Hansa Biopharma AB (24H) Balance Sheet

8 Followers

Hansa Biopharma AB Balance Sheet

Hansa Biopharma AB's total assets for Q3 2026 were kr1.93B, an increase of 79.91% from the previous quarter. DE:24H total liabilities were kr2.61B for the fiscal quarter, a 64.16% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
kr 1.17Bkr 800.64Mkr 1.02Bkr 1.69Bkr 1.01B
kr 1.25Bkr 1.39Bkr 1.19Bkr 1.08Bkr 255.24M
kr -84.13Mkr -589.83Mkr -167.88Mkr 602.91Mkr 757.57M

Currency in SEK

Hansa Biopharma AB Liabilities to Assets

0600M1.2B1.8B0 %80 %160 %240 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets